Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Robert Bracchi"'
Autor:
Sinead Brophy, David Tuthill, Jonathan Kennedy, Dyfrig Hughes, Hamish Laing, Rhiannon K Owen, Mike J Seaborne, Ayodele Vincent Opatola, Robert Bracchi
Publikováno v:
BMJ Paediatrics Open, Vol 8, Iss 1 (2024)
Objective To examine if the weight of a child determines adverse events following oral antibiotics prescription.Design Population respective cohort using linked general practice (GP), hospital data and linkage with the Welsh Demographic Service for d
Externí odkaz:
https://doaj.org/article/5110380c7cad43aa96f76151f1fb5fc0
Publikováno v:
PLoS ONE, Vol 12, Iss 4, p e0174730 (2017)
BACKGROUND:Hip fractures in the older person lead to an increased risk of mortality, poorer quality of life and increased morbidity. Benzodiazepine (BNZ) use is associated with increased hip fracture rate, consequently Z-drugs are fast becoming the p
Externí odkaz:
https://doaj.org/article/8e6c653517b44e9b8d7874da4a160dce
Publikováno v:
Adverse Drug Reaction Bulletin. 326:1263-1266
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::501902a45ec04b1a395944bed9e9d16d
https://doi.org/10.1097/fad.0000000000000053
https://doi.org/10.1097/fad.0000000000000053
Autor:
Mark D. Atkinson, Mitul Jadeja, Alana Adams, Jenna Walker, Fiona J. Woods, Foteini Tseliou, Pauline Ashfield-Watt, Philip A. Routledge, Alison S Thomas, Lauren Copeland, Robert Bracchi
Publikováno v:
British Journal of Clinical Pharmacology. 87:3344-3348
We used the HealthWise Wales (HWW) platform to explore public knowledge about the UK Yellow Card scheme (YCS), the spontaneous reporting scheme for suspected adverse drug reactions (ADRs) and whether a short information video could improve awareness.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::942080a737784459a1165ed5b5f3246e
https://doi.org/10.1111/bcp.14726
https://doi.org/10.1111/bcp.14726
There is considerable interest in repurposing metformin as an adjunctive therapy in the treatment of SARS-CoV-2 infection, COVID-19. The efficacy, optimum dose and relevant target-population are, however, undefined. This study used data from the Secu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::450eedb02f4a2f0541a1174b45ea391f
https://doi.org/10.22541/au.165496323.34410550/v1
https://doi.org/10.22541/au.165496323.34410550/v1
Autor:
Paul N. Deslandes, Robert Bracchi, Karen Jones, Kath E. Haines, Emma Carey, Alana Adams, Jenna Walker, Alison Thomas, Philip A. Routledge
Publikováno v:
British journal of clinical pharmacology. 88(8)
This study aimed to assess the impact of a National Reporting Indicator (NRI) on rates of reporting of suspected adverse drug reactions using the Yellow Card scheme following the introduction of the NRI in Wales (UK) in April 2014.Yellow Card reporti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::faccc53bd7046339564d43d051463597
https://pubmed.ncbi.nlm.nih.gov/35322450
https://pubmed.ncbi.nlm.nih.gov/35322450
Aims\ud \ud To review the medicines optimisation activities of the All Wales Medicines Strategy Group (AWMSG), a committee established in 2002 to advise the Welsh Government on “all matters related to prescribing”. Although AWMSG conducts other a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbd9269247a7de52a955ed072f4d4242
https://orca.cardiff.ac.uk/id/eprint/141996/1/bcp.14817.pdf
https://orca.cardiff.ac.uk/id/eprint/141996/1/bcp.14817.pdf
Publikováno v:
Pharmacoeconomics
Background The All Wales Medicines Strategy Group (AWMSG) develops prescribing advice and is responsible for appraising new medicines for use in Wales. In this article, we examine the medicines appraisal process in Wales, its timeliness and its impac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c0aace4c17bcdd0f35abb847fa28854
http://europepmc.org/articles/PMC5906524
http://europepmc.org/articles/PMC5906524
Autor:
Robert Bracchi, Philip A. Routledge, Alice Varnava, Dyfrig A. Hughes, Karen Samuels, Sabrina Rind
This chapter provides an overview of the process and criteria for accessing medicines in Wales through health technology assessment. The All Wales Medicines Strategy Group (AWMSG) is a statutory scientific advisory body that is responsible for apprai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a1ffe8e7deffebb2ab33bbd0ba276d1
https://doi.org/10.1016/b978-0-12-811945-7.00013-0
https://doi.org/10.1016/b978-0-12-811945-7.00013-0
Autor:
Zaheer-Ud-Din Babar, Darrin Baines, Robert Bracchi, Nadeem Irfan Bukhari, Louise E. Curley, Filipa Alves da Costa, Syed Shahzad Hasan, Dyfrig A. Hughes, Maree Jensen, Claudio Jommi, Brendan Kwesiga, Christine Y. Lu, Ana Paula Martins, Katrina Perehudoff, Sanya Ram, Khurram Rehman, Sabrina Rind, Philip A. Routledge, Karen Samuels, Morries Seru, Russell Shute, Ellen 't Hoen, Birna Trap, Alice Varnava, Agnes Isabelle Vitry, Sabine Vogler, Anita Katharina Wagner, Jennifer A. Whitty, Inthira Yamabhai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a013bb17bf17d274c8c62c3754a50949
https://doi.org/10.1016/b978-0-12-811945-7.00017-8
https://doi.org/10.1016/b978-0-12-811945-7.00017-8